Spectrum of FDG PET/CT Findings of Uterine Tumors
|
|
- Myles O’Neal’
- 6 years ago
- Views:
Transcription
1 Nuclear Medicine and Molecular Imaging Pictorial Essay Kitajima et al. FDG PET/CT of Uterine Tumors Nuclear Medicine and Molecular Imaging Pictorial Essay Downloaded from by on 12/10/17 from IP address Copyright RRS. For personal use only; all rights reserved Kazuhiro Kitajima 1,2 Koji Murakami 3 Yasushi Kaji 2 Kazuro Sugimura 1 Kitajima K, Murakami K, Kaji Y, Sugimura K Keywords: FDG PET/CT, MRI, oncologic imaging, uterine tumors, uterus DOI: /JR Received December 6, 2009; accepted after revision February 3, Department of Radiology, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo , Japan. ddress correspondence to K. Kitajima (kazu @yahoo.co.jp). 2 Department of Radiology, Dokkyo University School of Medicine, Mibu, Japan. 3 PET Center, Dokkyo Medical University Hospital, Mibu, Japan. CME This article is available for CME credit. See for more information. JR 2010; 195: X/10/ merican Roentgen Ray Society Spectrum of FDG PET/CT Findings of Uterine Tumors OJECTIVE. The purpose of this article is to review FDG PET/CT and MRI findings in a variety of benign and malignant tumors of the uterus and to become familiar with the wide variety of FDG PET/CT findings of this entity. CONCLUSION. enign uterine tumors generally have mild FDG uptake, and leiomyoma rarely shows high uptake. Uterine malignant tumors generally have intense FDG uptake, whereas malignant uterine tumors that are small or that have low cellular density often show minimal uptake. P ET/CT with 18F-FDG is increasingly being used for disease staging and restaging and for monitoring treatment of patients with various cancers. lthough FDG generally accumulates in malignant lesion because of high glucose metabolism, FDG can also accumulate in normal tissue, benign lesions, and tissues affected by inflammatory processes. Hence, knowledge of the wide variety of FDG PET/CT findings is important for the proper interpretation of FDG PET/CT scans. We illustrate the spectrum of FDG PET/CT findings in benign and malignant uterine tumors. Physiologic Endometrial Uptake Physiologic FDG endometrial uptake can be seen around the time of the first 3 days of menstruation and the ovulatory phase of the menstrual cycle in premenopausal women. Lerman et al. [1] reported that the mean endometrial standardized uptake values (SUVs) in premenopausal women were 5 ± 3.2 (SD) and 3.7 ± 0.9 during the menstruating and ovulating phases, respectively, and 2.6 ± 1.1 and 2.5 ± 1.1 during the proliferative and secretory phases, respectively. They also reported that the mean endometrial SUV of postmenopausal women receiving hormonal therapy was 1.7 ± 0.7 (range, ) and that hormonal therapy in postmenopausal women was not associated with a significant alteration in endometrial FDG uptake. Increased FDG endometrial uptake in postmenopausal women may indicate malignancy. enign Tumors Uterine Leiomyoma Uterine leiomyomas usually show mild FDG uptake (Fig. 1) but sometimes show intense uptake (Fig. 2). Chura et al. [2] reported leiomyomas showing very high SUVs in three patients: One case was an ordinary leiomyoma of 13 mm (SUV = 16), the second was a cellular leiomyoma of 30 mm (SUV = 9.3), and the third was a stromomyoma (SUV = 6). lthough the exact mechanism responsible for high FDG uptake in leiomyomas is unclear, the phenomenon would be regulated by several factors including hormonal dependency, cellularity (the number of viable tumor cells), vascularity (microvessel density), tumor cell proliferation (the expression of growth factors such as basic fibroblast growth factor, transforming growth factor β, granulocyte-macrophage colony-stimulating factor, and Ki- 67 and their receptors), expression of glucose transporter 1 (GLUT-1) and hexokinase, the existence of endometrial tissue, and the presence of inflammatory cells [3, 4]. Leiomyomas with FDG uptake are more common in premenopausal women than postmenopausal women [3, 4]. Nishizawa et al. [3] reported that the incidence of FDG uptake in premenopausal women with leiomyomas (10.4% of 164 women) was higher than that in postmenopausal women with leiomyomas (1.2% of 338 women). They also showed that leiomyoma in premenopausal women tends to show higher uptake during a luteal phase than during menstrual flow and the follicular and periovulatory phases. lthough JR:195, September
2 Kitajima et al. Downloaded from by on 12/10/17 from IP address Copyright RRS. For personal use only; all rights reserved they reported that degenerated leiomyomas showing high signal intensity on T2-weighted MR images (Fig. 3) tend to show higher FDG uptake than nondegenerated leiomyoma showing low signal intensity on T2-weighted MR images [3, 4], nondegenerated leiomyoma can often show high uptake (Fig. 2). denomyosis lthough adenomyosis generally shows mild FDG uptake (Fig. 4) in premenopausal women, it often shows higher uptake during the menstruating and ovulating phases. Endometrial Hyperplasia Endometrial hyperplasia mainly shows mild FDG uptake (Fig. 5). Tsujikawa et al. [5] reported that the mean SUV of endometrial cancer in nine patients was 9.6 ± 3.3 (SD) (range, ) and that the mean SUV of endometrial hyperplasia in four patients was 1.7 ± 0.3 (range, ). lthough the SUV values endometrial cancer and endometrial hyperplasia did not overlap, a study of larger sample size is warranted. Malignant Tumors Uterine Cervical Cancer lthough uterine cervical cancer generally shows intense FDG uptake (Fig. 6), small malignant tumors and malignant tumors with low cellular density may not show FDG uptake (Fig. 7) because of the limited spatial resolution of the PET machine (i.e., the partial volume effect). Kidd et al. [6, 7] reported that mean maximum SUV (SUV max ) of cervical cancer in 287 patients was 11.4 (range, ). No correlation was noted between SUV max and International Federation of Gynecology and Obstetrics (FIGO) stage and tumor volume [6, 7]. Squamous cell carcinomas have been reported to tend to show higher SUV max values than nonsquamous cell carcinomas and poorly differentiated carcinomas have been reported to tend to show higher SUV max values than well- or moderately differentiated carcinomas [6]. Higher SUV max values were associated with an increased risk of lymph node metastasis [6, 7].Several authors have shown that FDG PET/CT of patients with uterine cervical cancer who have not yet received treatment to determine the SUV of the primary cancer, lymph node status, endometrial extension, and so on may be a sensitive biomarker of treatment response and prognosis [6 10]. Compared with MRI, PET/CT has a limited role for local staging of primary cancer (Fig. 6), whereas PET/CT is useful for assessing distant metastases throughout the whole body in a single examination in patients with advanced-stage disease. lthough PET/CT can detect normal-sized lymph node metastases from 5 to 9 mm, which conventional CT and MRI cannot diagnose, even PET/CT cannot detect micrometastases, the size of which is under a PET machine s sensitivity [11]. Minimal-deviation adenocarcinoma showed moderate FDG uptake (Fig. 8). lthough FDG PET could be used for the differential diagnosis of minimal-deviation adenocarcinoma from nabothian cyst, a study of larger sample size is warranted. Endometrial Cancer lthough endometrial cancer generally shows intense FDG uptake (Fig. 9), small malignant tumors or malignant tumors with low cellular density may not show uptake because of the limited spatial resolution of the PET machine. Kitajima et al. [12] reported that the mean SUV of endometrial cancer in 40 patients was 11.2 ± 5.9 (SD) (range, ). Few reports discussing FDG PET/ CT of endometrial cancer are available to date in the medical literature. Compared with MRI, PET/CT has a limited role for local staging of primary cancer (Fig. 9), whereas PET/CT is a useful technique for assessing distant metastases throughout the whole body in a single examination in patients with advanced-stage disease. lthough PET/CT can often detect normal-sized lymph node metastases from 5 to 9 mm, which conventional CT and MRI cannot diagnose (Fig. 10), even PET/CT cannot detect micrometastasis, the size of which is under a PET machine s sensitivity [12]. Leiomyosarcoma Uterine leiomyosarcoma usually shows moderate to intense FDG uptake (Fig. 11). Umesaki et al. [13] reported that SUVs of uterine leiomyosarcoma in two patients were 3.0 and 3.9, and Tsujikawa et al. [5] reported that mean SUV of uterine leiomyosarcoma in four patients was 6.4 ± 4.3 (SD) (range, ). ecause uterine leiomyoma rarely shows high FDG uptake (Fig. 2) and leiomyosarcoma rarely shows mild FDG uptake (Fig. 12), unfortunately FDG PET cannot be used to differentiate leiomyosarcoma from leiomyoma. Other Uterine Sarcomas Endometrial stromal sarcoma (Fig. 13) and uterine carcinosarcoma (Fig. 14) generally show intense FDG uptake. Ho et al. [14] reported that the mean SUV of uterine carcinosarcoma in 19 patients was 10.3 ± 5.5 (range, ). Uterine Metastatic Tumor Uterine metastatic tumors generally show intense FDG uptake (Fig. 15). References 1. Lerman H, Metser U, Grisaru D, Fishman, Lievshitz G, Even-Spair E. Normal and abnormal 18 F-FDG endometrial and ovarian uptake in preand postmenopausal patients: assessment by PET/ CT. J Nucl Med 2004; 45: Chura JC, Truskinovsky M, Judson PL, Johnson L, Geller M, Downs LS. Positron emission tomography and leiomyomas: clinical analysis of 3 cases of PET scan-positive leiomyomas and literature review. Gynecol Oncol 2007; 104: Nishizawa S, Inubushi M, Kido, et al. Incidence and characteristics of uterine leiomyomas with FDG uptake. nn Nucl Med 2008; 22: Kitajima K, Murakami K, Yamasaki E, Kaji Y, Sugimura K. Standardized uptake values of uterine leiomyoma with 18 F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI. nn Nucl Med 2008; 22: Tsujikawa T, Yoshida Y, Mori T, et al. Uterine tumors: pathophysiologic imaging with 16α-[ 18 F] fluoro-17β-estradiol and 18 F-fluorodeoxyglucose PET initial experience. Radiology 2008; 248: Kidd E, Spencer CR, Heuttner PC, et al. Cervical cancer histology and tumor differentiation affect 18 F-fluorodeoxyglucose uptake. Cancer 2009; 115: Kidd E, Siegel, Dehdashti F, Grigsby PW. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer 2007; 110: Singh K, Grigsby W, Dehdasht F, Herzog T, Siegel. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma. Int J Radiat Oncol iol Phys 2003; 56: Hope J, Saha P, Grigsby PW. FDG-PET in carcinoma of the uterine cervix with endometrial extension. Cancer 2006; 106: Yen TC, See LC, Lai CH, et al. Standardized uptake in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer. Eur J Nucl Med Mol Imaging 2008; 35: Sironi S, uda, Picchio M, et al. Lymph node metastasis in patients with clinical early-stage 738 JR:195, September 2010
3 FDG PET/CT of Uterine Tumors cervical cancer: detection with integrated FDG PET/CT. Radiology 2006; 238: Kitajima K, Murakami K, Yamasaki E, et al. ccuracy of FDG PET/CT in detecting pelvic and paraortic lymph node metastasis in patients with endometrial cancer. JR 2008; 190: Umesaki N, Tanaka T, Miyama M, et al. Positron emission tomography with 18 F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging. Gynecol Oncol 2001; 80: Ho KC, Lai CH, Wu TI, et al. 18 F-fluorodeoxyglucose positron emission tomography in uterine carcinosarcoma. Eur J Nucl Med Mol Imaging 2008; 35: Downloaded from by on 12/10/17 from IP address Copyright RRS. For personal use only; all rights reserved Fig year-old woman with leiomyoma showing imaging findings typical of leiomyoma., Ordinary nondegenerated leiomyoma measuring 5.5 cm shows homogeneous low signal intensity on T2-weighted MR image., On PET/CT image, leiomyoma shows faint FDG uptake with maximum standardized uptake value of 2.0. Fig year-old woman with leiomyoma showing unusual imaging findings., Ordinary nondegenerated leiomyoma (arrow) measuring 1.3 cm shows homogeneous low signal intensity on T2-weighted image., On PET/CT image, leiomyoma (arrow) shows uptake value of 8.5. Fig year-old woman with leiomyoma showing imaging findings typical of leiomyoma., Degenerated leiomyoma measuring 6.0 cm shows heterogeneous mixed low and high signal intensity on T2-weighted image., On PET/CT image, leiomyoma shows moderate FDG uptake with maximum standardized uptake value of 3.9. JR:195, September
4 Kitajima et al. Fig year-old woman with diffuse adenomyosis., Diffuse adenomyosis shows low signal intensity with hyperintense tiny foci in enlarged myometrium on T2-weighted image., On PET/CT image, adenomyosis shows mild FDG uptake with maximum standardized uptake value of 2.5. Downloaded from by on 12/10/17 from IP address Copyright RRS. For personal use only; all rights reserved Fig year-old woman with endometrial hyperplasia., Endometrial hyperplasia shows thick endometrium on T2-weighted image., On PET/CT image, endometrial hyperplasia (arrow) shows faint FDG uptake with maximum standardized uptake value of 2.0. Fig year-old woman with advanced-stage uterine cervical cancer., Uterine cervical cancer shows heterogeneous high signal intensity invades right parametrium on T2-weighted image (International Federation of Gynecology and Obstetrics [FIGO] stage IIb)., On PET/CT image, uterine cervical cancer shows uptake value of Whether there is invasion of parametrium is not clear on PET/CT. 740 JR:195, September 2010
5 FDG PET/CT of Uterine Tumors Fig year-old woman with early-stage uterine cervical cancer., Uterine cervical cancer (arrow) shows high signal intensity is localized in cervix (International Federation of Gynecology and Obstetrics stage Ib) on T2-weighted image., On PET/CT image, tiny uterine cervical cancer shows no abnormal FDG uptake. Downloaded from by on 12/10/17 from IP address Copyright RRS. For personal use only; all rights reserved Fig year-old woman with minimal-deviation adenocarcinoma., Minimal-deviation adenocarcinoma appears multilobulated and shows high signal intensity on T2- weighted image., On PET/CT image, minimal-deviation adenocarcinoma shows moderate FDG uptake with maximum standardized uptake value of 5.3. Fig year-old woman with endometrial cancer involving lymph node., Endometrial cancer shows heterogeneous high signal intensity invades myometrium on T2-weighted image (International Federation of Gynecology and Obstetrics stage Ib). MRI shows right internal iliac lymphadenopathy measuring 2.8 cm, suggesting presence of nodal cancer spread., On PET/CT image, endometrial cancer shows strong FDG uptake with maximum standardized uptake value of Whether there is invasion of myometrium is not clear on PET/CT. PET/CT shows abnormal uptake corresponding to right internal iliac lymph node, clarifying presence of nodal cancer spread. JR:195, September
6 Kitajima et al. Downloaded from by on 12/10/17 from IP address Copyright RRS. For personal use only; all rights reserved Fig year-old woman with bilateral internal lymph node metastases due to endometrial cancer., MR image shows two small lymph nodes measuring 7 mm in bilateral internal iliac areas (arrows), but it is difficult to diagnose lymph node metastases because of size criterion., PET/CT image shows abnormal uptake corresponds to two small lymph nodes (arrows), clarifying presence of nodal cancer spread. Histopathology results confirmed this imaging finding. Fig year-old woman with uterine leiomyosarcoma showing imaging findings typical of leiomyosarcoma., Huge uterine tumor shows heterogeneous high signal intensity with omentum involvement on T2- weighted image., On PET/CT image, huge uterine tumor shows uptake value of Omental and peritoneal dissemination (arrows) also show strong FDG uptake. Fig year-old woman with uterine leiomyosarcoma showing unusual imaging findings., Huge uterine tumor shows heterogeneous high and low signal mixed intensity on T2-weighted image., On PET/CT image, huge uterine tumor shows moderate FDG uptake with maximum standardized uptake value of JR:195, September 2010
7 FDG PET/CT of Uterine Tumors Downloaded from by on 12/10/17 from IP address Copyright RRS. For personal use only; all rights reserved FOR YOUR INFORMTION This article is available for CME credit. See for more information. Fig year-old woman with endometrial stromal sarcoma., MR image reveals hyperintense endometrial tumor showing extensive myometrial involvement with bands of low signal intensity on T2-weighted image. Tumor thrombus (arrow) in left ovarian vessel is suspected., On PET/CT image, huge uterine tumor shows uptake value of 8.2. Tumor thrombus (arrow) with intense uptake is seen in left ovarian vessel. Fig year-old woman with carcinosarcoma., Uterine polypoid mass in cavity of uterine body shows high and low signal intensity on T2-weighted image., On PET/CT image, uterine tumor shows strong FDG uptake with maximum standardized uptake value of Fig year-old woman with uterine metastatic tumor from gastric cancer., Two masses in myometrium show heterogeneous low signal intensity on T2-weighted image., On PET/CT image, two uterine tumors show strong FDG uptake with maximum standardized uptake value of 13.4 and JR:195, September
FDG-PET/CT in Gynaecologic Cancers
Friday, August 31, 2012 Session 6, 9:00-9:30 FDG-PET/CT in Gynaecologic Cancers (Uterine) cervical cancer Endometrial cancer & Uterine sarcomas Ovarian cancer Little mermaid (Edvard Eriksen 1913) honoring
More informationThe role of PET/CT in the management of Gynaecological Malignancies. Dr Patrick Fielding Consultant Radiologist PETIC UHW 19 th November 2010
The role of PET/CT in the management of Gynaecological Malignancies Dr Patrick Fielding Consultant Radiologist PETIC UHW 19 th November 2010 Thank you! 1998-2003 2003-2006 2006-2010 ABMU LHB Cheltenham
More informationWhat is endometrial cancer?
Uterine cancer What is endometrial cancer? Endometrial cancer is the growth of abnormal cells in the lining of the uterus. The lining is called the endometrium. Endometrial cancer usually occurs in women
More informationRole of PET/CT in Ovarian Cancer
Residents Section Structured Review rticle Prakash et al. PET/T in Ovarian ancer Residents Section Structured Review rticle Downloaded from www.ajronline.org by 148.251.232.83 on 04/26/18 from IP address
More informationNew Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%
Uterine Malignancy New Cancer Cases By Site 2010 Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3% Cancer Deaths By Site 2010 Lung 26% Breast 15% Colo-Rectal 9% Pancreas 7%
More informationChapter 2: Initial treatment for endometrial cancer (including histologic variant type)
Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?
More informationFDG-PET Findings in an Ovarian Endometrioma: A Case Report
FDG-PET Findings in an Ovarian Endometrioma: A Case Report Jia-Huei Lin 1, Victor Chit-kheng Kok 2, Jian-Chiou Su 3 1 Department of Nuclear medicine, Kuang Tien General Hospital, Sha-Lu, Taichung, Taiwan
More informationCervical Cancer: 2018 FIGO Staging
Cervical Cancer: 2018 FIGO Staging Jonathan S. Berek, MD, MMS Laurie Kraus Lacob Professor Stanford University School of Medicine Director, Stanford Women s Cancer Center Senior Scientific Advisor, Stanford
More informationStaging and Treatment Update for Gynecologic Malignancies
Staging and Treatment Update for Gynecologic Malignancies Bunja Rungruang, MD Medical College of Georgia No disclosures 4 th most common new cases of cancer in women 5 th and 6 th leading cancer deaths
More informationPET/CT in Gynaecological Cancers. Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp
PET/CT in Gynaecological Cancers Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp Cervix cancer Outline of this talk Initial staging Treatment monitoring/guidance
More informationEndometrial Stromal Sarcoma
May 26, 2011 By Sushila Ladumor, MD [1] Endometrial stromal sarcoma (ESS) is a rare malignant tumor of the endometrium, occurring in the age group of 40-50 years. History The 50-year-old, female patient
More informationOne of the commonest gynecological cancers,especially in white Americans.
Gynaecology Dr. Rozhan Lecture 6 CARCINOMA OF THE ENDOMETRIUM One of the commonest gynecological cancers,especially in white Americans. It is a disease of postmenopausal women with a peak incidence in
More informationJMSCR Vol 05 Issue 06 Page June 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i6.29 MRI in Clinically Suspected Uterine and
More informationThe new FIGO classification in endometrial carcinoma
The new FIGO classification in endometrial carcinoma Poster No.: C-1073 Congress: ECR 2012 Type: Educational Exhibit Authors: A. IGLESIAS CASTAÑON, M. Arias Gonzales, J. Mañas Uxó, 1 2 1 2 2 2 B. NIETO
More information3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates
J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates Signs
More informationCT and MRI of Uterine Sarcomas and Their Mimickers
Downloaded from www.ajronline.org by 37.44.206.60 on 01/10/18 from IP address 37.44.206.60. Copyright RRS. For personal use only; all rights reserved CT and MRI of Uterine Sarcomas and Their Mimickers
More informationPositron Emission Tomography in Detection of Metastatic Leiomyosarcoma in a Postoperative Patient: A Case Report
Positron Emission Tomography in Detection of Metastatic Leiomyosarcoma in a Postoperative Patient: A Case Report David B. Engle, MD., 1 Linda M. Smiley, MD., 2 Scott L. Baum, MD., 3 Greg P. Wellman, MD.
More informationPet Scan And Gynaecological Malignancies: Hospital Sultanah Bahiyah Experience
ORIGINAL ARTICLE Pet Scan And Gynaecological Malignancies: Hospital Sultanah Bahiyah Experience T Shahila, MMED (O&G), M N Rushdan, MMED (O&G) Gynaecological Oncology Unit, Department of Obstetrics & Gynaecology,
More informationFDG-PET value in deep endometriosis
Gynecol Surg (2011) 8:305 309 DOI 10.1007/s10397-010-0652-6 ORIGINAL ARTICLE FDG-PET value in deep endometriosis A. Setubal & S. Maia & C. Lowenthal & Z. Sidiropoulou Received: 3 December 2010 / Accepted:
More informationGenitourinary Imaging Pictorial Essay
rown et al. MRI of the Female Pelvis Genitourinary Imaging Pictorial Essay Downloaded from www.ajronline.org by 37.44.202.41 on 12/17/17 from IP address 37.44.202.41. Copyright RRS. For personal use only;
More informationCurrent staging of endometrial carcinoma with MR imaging
Current staging of endometrial carcinoma with MR imaging Poster No.: C-1436 Congress: ECR 2015 Type: Educational Exhibit Authors: M. Magalhaes, H. Donato, C. B. Marques, P. Gomes, F. Caseiro Alves; Coimbra/PT
More informationCase Scenario 1. History
History Case Scenario 1 A 53 year old white female presented to her primary care physician with post-menopausal vaginal bleeding. The patient is not a smoker and does not use alcohol. She has no family
More informationINTRAUTERINE DEVICE = IUD INTRAUTERINE DEVICE = IUD CONGENITAL DISORDERS Pyometra = pyometrea is a uterine infection, it is accumulation of purulent material in the uterine cavity. Ultrasound is usually
More informationC ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)
CLINICAL C ORPUS UTERI C ARCINOMA STAGING FORM PATHOLOGIC Extent of disease before S TAGE C ATEGORY D EFINITIONS Extent of disease through any treatment completion of definitive surgery y clinical staging
More informationPET-CT findings in surgically transposed ovaries
The British Journal of Radiology, 79 (2006), 110 115 1,2,3 R ZISSIN, MD, 1 U METSER, MD, 1 H LERMAN, MD, 1 G LIEVSHITZ, MD, 4 T SAFRA, MD and 1,3 E EVEN-SAPIR, MD, PhD Department of 1 Nuclear Medicine
More informationUTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS
Review Journal of Translational Medicine and Research, volume 19, no. 1-2, 2014 UTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS N. Bacalbaæa 1, A. Traistaru 2, I. Bãlescu 3 1 Carol Davila University of Medicine
More informationCigdem Soydal 1,*, Erkan Ibıs 1, Fırat Ortac 2, Elgin Ozkan 1, Ozlem N. Kucuk 1 and K. Metin Kir 1
International Journal of Nuclear Medicine Research, 2014, 1, 1-6 1 The Role of 18F-Flourodeoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) in Pelvic and Paraaortic Lymph
More informationMR imaging of FIGO stage I uterine cervical cancer: The diagnostic impact of 3T-MRI
MR imaging of FIGO stage I uterine cervical cancer: The diagnostic impact of 3T-MRI Poster No.: C-1191 Congress: ECR 2010 Type: Educational Exhibit Topic: Genitourinary Authors: M. Takeuchi, K. Matsuzaki,
More informationMPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?
MPH Quiz Case 1 Surgical Pathology from hysterectomy performed July 11, 2007 Final Diagnosis: Uterus, resection: Endometrioid adenocarcinoma, Grade 1 involving most of endometrium, myometrial invasion
More informationImaging in gastric cancer
Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.
More informationMOLECULAR AND CLINICAL ONCOLOGY 5: , 2016
MOLECULAR AND CLINICAL ONCOLOGY 5: 467-474, 2016 Prognostic impact of primary tumor SUV max on preoperative 18 F fluoro 2 deoxy D glucose positron emission tomography and computed tomography in endometrial
More informationC ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)
C ORPUS UTERI C ARCINOMA STAGING FORM CLINICAL Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery Tis * T1 I T1a IA NX N0 N1 N2
More informationPre-operative Evaluation and Implications
Pre-operative Evaluation and Implications Michal Zikan Gynecologic Oncology Center Charles University in Prague, First Faculty of Medicine No recommendation for screening of EC (HNPCC annual biopsies starting
More informationValue of imaging study in predicting pelvic lymph node metastases of uterine cervical cancer
Original Article Radiat Oncol J 2017;35(4):340-348 pissn 2234-1900 eissn 2234-3156 Value of imaging study in predicting pelvic lymph node metastases of uterine cervical cancer Wonguen Jung, MD 1, Kyung
More informationEndometrial carcinoma is a highly prevalent gynecologic
Functional Images Reflect Aggressiveness of Endometrial Carcinoma: Estrogen Receptor Expression Combined with F-FDG PET Tetsuya Tsujikawa 1, Yoshio Yoshida 2, Takashi Kudo 1, Yasushi Kiyono 1, Tetsuji
More informationStaging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion
5 th of June 2009 Background Most common gynaecological carcinoma in developed countries Most cases are post-menopausal Increasing incidence in certain age groups Increasing death rates in the USA 5-year
More informationUnusual Osteoblastic Secondary Lesion as Predominant Metastatic Disease Spread in Two Cases of Uterine Leiomyosarcoma
49 Unusual Osteoblastic Secondary Lesion as Predominant Metastatic Disease Spread in Two Cases of Uterine Leiomyosarcoma Loredana Miglietta a Maria Angela Parodi b Luciano Canobbio b Luca Anselmi c a Medical
More informationTitle: Positron Emission Tomography (PET) for Staging Cervical Cancer: Clinical Effectiveness and Guidelines for Use
Title: Positron Emission Tomography (PET) for Staging Cervical Cancer: Clinical Effectiveness and Guidelines for Use Date: 16 July 2008 Research question: 1. What is the clinical effectiveness of positron
More informationKey words: Adenocarcinoma, Adenomyosis, Biopsy, Ovary, Small Cell Lung Carcinoma.
JOURNAL OF CASE REPORTS 2016;6(2):182-187 Safety and Feasibility of CT-Guided Core Biopsy for Gynecologic Lesions: Case Series Yusuke Manabe 1, Tsuyoshi Tajima 1, Tetsu Yano 2, Toshifumi Masuda 1, Takashi
More informationThe International Federation of Gynecology and Obstetrics (FIGO) updated the staging
Continuing Education Column Revised FIGO Staging System Hee Sug Ryu, MD Department of Obstetrics and Gynecology, Ajou University School of Medicine E - mail : hsryu@ajou.ac.kr J Korean Med Assoc 2010;
More informationDisclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None
What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Zhen Jane Wang, MD Assistant Professor in Residence UC SF Department of Radiology Disclosure None Acknowledgement Hueylan Chern, MD, Department
More informationMRI in Cervix and Endometrial Cancer
28th Congress of the Hungarian Society of Radiologists RCR Session Budapest June 2016 MRI in Cervix and Endometrial Cancer DrSarah Swift St James s University Hospital Leeds, UK Objectives Cervix and endometrial
More informationThe type of metastasis is a prognostic factor in disseminated cervical cancer
J Gynecol Oncol Vol. 21, No. 3:186-190, September 2010 DOI:10.3802/jgo.2010.21.3.186 Original Article The type of metastasis is a prognostic factor in disseminated cervical cancer Kidong Kim 1, Soo Youn
More informationStaging recurrent ovarian cancer with 18 FDG PET/CT
ONCOLOGY LETTERS 5: 593-597, 2013 Staging recurrent ovarian cancer with FDG PET/CT SANJA DRAGOSAVAC 1, SOPHIE DERCHAIN 2, NELSON M.G. CASERTA 3 and GUSTAVO DE SOUZA 2 1 DIMEN Medicina Nuclear and PET/CT
More informationDr Sneha Shah Tata Memorial Hospital, Mumbai.
Dr Sneha Shah Tata Memorial Hospital, Mumbai. Topics covered Lymphomas including Burkitts Pediatric solid tumors (non CNS) Musculoskeletal Ewings & osteosarcoma. Neuroblastomas Nasopharyngeal carcinomas
More informationLos Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010
Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010 Self Assessment Module on Nuclear Medicine and PET/CT Case Review FDG PET/CT IN LYMPHOMA AND MELANOMA Submitted
More informationCitation for published version (APA): van Kruchten, M. (2015). Molecular imaging of estrogen receptors [Groningen]: University of Groningen
University of Groningen Molecular imaging of estrogen receptors van Kruchten, Michel IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please
More informationIndex. B Bilateral salpingo-oophorectomy (BSO), 69
A Advanced stage endometrial cancer diagnosis, 92 lymph node metastasis, 92 multivariate analysis, 92 myometrial invasion, 92 prognostic factors FIGO stage, 94 histological grade, 94, 95 histologic cell
More informationREVIEW. Typical and atypical metastatic sites of recurrent endometrial carcinoma
Cancer Imaging (2013) 13(1), 113 122 DOI: 10.1102/1470-7330.2013.0011 REVIEW Typical and atypical metastatic sites of recurrent endometrial carcinoma Vikram Kurra a, Katherine M. Krajewski a,b, Jyothi
More informationCan the Ovaries be preserved in Selected Cases of Endometrial Cancer?
Can the Ovaries be preserved in Selected Cases of Endometrial Cancer? Parekh C D 1*, Desai A D 2, Patel B M 3, Patel S M 4, Mankad M H 5 1 Assistant Professor,Department of Gynaecologic Oncology, Gujarat
More informationFDG-PET/CT for cancer management
195 REVIEW FDG-PET/CT for cancer management Hideki Otsuka, Naomi Morita, Kyo Yamashita, and Hiromu Nishitani Department of Radiology, Institute of Health Biosciences, The University of Tokushima, Graduate
More informationCLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION
Donald L. Renfrew, MD Radiology Associates of the Fox Valley, 333 N. Commercial Street, Suite 100, Neenah, WI 54956 2/12/2011 Radiology Quiz of the Week # 7 Page 1 CLINICAL PRESENTATION AND RADIOLOGY QUIZ
More informationVaginal Cancer Early Detection, Diagnosis, and Staging
Vaginal Cancer Early Detection, Diagnosis, and Staging Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that can be
More informationGynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy
Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy Stephanie Yap, M.D. University Gynecologic Oncology Northside Cancer Institute Our Learning Objectives Review survival rates,
More informationreceive adjuvant chemotherapy
Women with high h risk early stage endometrial cancer should receive adjuvant chemotherapy Michael Friedlander The Prince of Wales Cancer Centre and Royal Hospital for Women The Prince of Wales Cancer
More informationEndometrial Cancer. Incidence. Types 3/25/2019
Endometrial Cancer J. Anthony Rakowski DO, FACOOG MSU SCS Board Review Coarse Incidence 53,630 new cases yearly 8,590 deaths yearly 4 th most common malignancy in women worldwide Most common GYN malignancy
More informationCase 1. Gynaecology Case Presentation. Objectives. Disclosures 22/10/ year old female Clinical history: Assess right ovarian cyst
Gynaecology Case Presentation Organ Imaging 2016 University of Toronto Sarah Johnson 39 year old female Clinical history: Assess right ovarian cyst Clinically diagnosed endometriosis Started fertility
More informationEndometrial line thickness in different conditions.
Endometrial line thickness in different conditions 1 Endometrial thickens in response to Rising estrogen levels during the menstrual cycle and then shedding endometrial at the times of menses 2 The thickens
More informationIndex. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic
More informationPET/CT in breast cancer staging
PET/CT in breast cancer staging Anni Morsing Consultant, PhD, DMSc Rigshospitalet 1 18F- FDG PET/CT for breastcancer staging Where is the clinical impact? To which women should 18F- FDG PET/CT be offered?
More informationA Rare Case of Invasive Squamous Cell Carcinoma of Cervix Extending to Endometrium and Right Fallopian Tube
A Rare Case of Invasive Squamous Cell Carcinoma of Cervix Extending to Endometrium and Right Fallopian Tube Kate Madhuri S 1, Gulhane Sushma R 2, Mane Sheetal V 3 1 Professor and Head, 2 Specialist cum
More information2009 USCAP Gyn Pathology Evening Session Case #3. Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA
2009 USCAP Gyn Pathology Evening Session Case #3 Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA rzaino@psu.edu Clinical history Middle aged woman with an exophytic mass of
More informationVIII. 9. FDG-PET for Diagnosis of an Advanced Jejunal Adenocarcinoma with Distant Metastases, Compared with Gallium Scintigraphy
CYRIC Annual Report 2003 VIII. 9. FDG-PET for Diagnosis of an Advanced Jejunal Adenocarcinoma with Distant Metastases, Compared with Gallium Scintigraphy Yamaura G., Yoshioka T., Yamaguchi K. *, Fukuda
More informationTHE VALUE OF F-18 FDG-PET IN INVASIVE CERVICAL CANCER
THE VALUE OF F-18 FDG-PET IN INVASIVE CERVICAL CANCER BY: DR FAIZA MAHOMED DEPARTMENT OF RADIATION ONCOLOGY AND DEPARTMENT OF NUCLEAR MEDICINE CHARLOTTE MAXEKE JOHANNESBURG ACADEMIC HOSPITAL JOHANNESBURG,
More informationCase Report Serous Ovarian Carcinoma Recurring as Malignant Mixed Mullerian Tumor
Case Reports in Obstetrics and Gynecology Volume 2015, Article ID 612824, 5 pages http://dx.doi.org/10.1155/2015/612824 Case Report Serous Ovarian Carcinoma Recurring as Malignant Mixed Mullerian Tumor
More informationUTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE
UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE Case: Adenosarcoma with heterologous elements and stromal overgrowth o TAH, BSO, omentectomy, staging biopsies of cul-de-sac, bladder
More informationPET CT for Staging Lung Cancer
PET CT for Staging Lung Cancer Rohit Kochhar Consultant Radiologist Disclosures Neither I nor my immediate family members have financial relationships with commercial organizations that may have a direct
More informationPET/CT for Adrenal Assessment
Residents Section Structured Review rticle lake et al. PET/CT of the drenal Glands Residents Section Structured Review rticle Michael. lake 1 Priyanka Prakash Carmel G. Cronin lake M, Prakash P, Cronin
More informationRecurrent Ovarian Cancer: Spectrum of Imaging Findings
Recurrent Ovarian Cancer Women s Imaging Pictorial Essay Downloaded from www.ajronline.org by 80.243.130.157 on 03/08/18 from IP address 80.243.130.157. Copyright RRS. For personal use only; all rights
More informationGynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer
Gynecologic Oncology Pre invasive vulvar, vaginal, & cervical disease Vulvar Cervical Endometrial Uterine Sarcoma Fallopian Tube Ovarian GTD Gynecologic Oncologist Surgery Chemotherapy Radiation Therapy
More informationKieran Sultan, PGY4 Penrose St. Francis Hospital
Kieran Sultan, PGY4 Penrose St. Francis Hospital 67 G3, P3 female with no routine medical care and PMH of DM-2. Presented to the ED 10 days after a road trip c/o SOB, intermittent nonproductive cough and
More informationLYMPHATIC DRAINAGE IN THE HEAD & NECK
LYMPHATIC DRAINAGE IN THE HEAD & NECK Like other parts of the body, the head and neck contains lymph nodes (commonly called glands). Which form part of the overall Lymphatic Drainage system of the body.
More informationPlease complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE
Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES PHYSICAL EXAMINATION CASE 1: FEMALE REPRODUCTIVE 3/5 Patient presents through the emergency room with
More informationWhat Radiologists do?
Multimodality Imaging in Oncology 2018 March 5 th 9th Diagnostic Imaging in Oncology What Radiologists do? Chikako Suzuki, MD, PhD Department of Diagnostic Radiology, KS Solna Department of Molecular Medicine
More information5 Mousa Al-Abbadi. Ola Al-juneidi & Obada Zalat. Ahmad Al-Tarefe
5 Mousa Al-Abbadi Ola Al-juneidi & Obada Zalat Ahmad Al-Tarefe Abnormal Uterine Bleeding (AUB) AUB is a very common scenario or symptom where women complain of menorrhagia (heavy and/or for long periods),
More informationAnnual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013
bs_bs_banner doi:10.1111/jog.12360 J. Obstet. Gynaecol. Res. Vol. 40, No. 2: 338 348, February 2014 Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013 Daisuke
More informationFemale Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan
Female Genital Tract Lab Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan Ovarian Pathology A 20-year-old female presented with vague left pelvic pain. Pelvic exam revealed
More informationAn Unusual Case of Cervical Cancer with Inguinal Lymph Node Metastasis: A Case Report and Review of the Literature
Archives of Clinical and Medical Case Reports doi: 10.26502/acmcr.9655003 Volume 1, Issue 1 Case Report An Unusual Case of Cervical Cancer with Inguinal Lymph Node Metastasis: A Case Report and Review
More informationPrimary tumor SUV max on preoperative FDG-PET/CT is a prognostic indicator in stage IA2-IIB cervical cancer patients treated with radical hysterectomy
216 Primary tumor SUV max on preoperative FDG-PET/CT is a prognostic indicator in stage IA2-IIB cervical cancer patients treated with radical hysterectomy SHIGETAKA YAGI 1, TAMAKI YAHATA 1, YASUSHI MABUCHI
More informationperformed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.
Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician
More informationArticle begins on next page
Scalp metastasis as a presenting symptom of Cervical Squamous Cell Carcinoma Rutgers University has made this article freely available. Please share how this access benefits you. Your story matters. [https://rucore.libraries.rutgers.edu/rutgers-lib/50623/story/]
More informationPET/CT for the evaluation of gynecological
PET/CT for the evaluation of gynecological cancer Gynecological cancer Barcelona, September 16 th 2018 Dr. Pilar Paredes, MD, PhD Nuclear Medicine Department Hospital Clínic Barcelona (Spain) PET/CT in
More informationUsing PET/CT in Prostate Cancer
Using PET/CT in Prostate Cancer Legal Disclaimer These materials were prepared in good faith by MITA as a service to the profession and are believed to be reliable based on current scientific literature.
More informationMody. AIS vs. Invasive Adenocarcinoma of the Cervix
Common Problems in Gynecologic Pathology Michael T. Deavers, M.D. Houston Methodist Hospital, Houston, Texas Common Problems in Gynecologic Pathology Adenocarcinoma in-situ (AIS) of the Cervix vs. Invasive
More informationبسم هللا الرحمن الرحيم. Prof soha Talaat
بسم هللا الرحمن الرحيم Ovarian tumors The leading indication for gynecologic surgery. Preoperative characterization of complex solid and cystic adnexal masses is crucial for informing patients about possible
More informationUPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER
UPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER Susan Davidson, MD Professor Department of Obstetrics and Gynecology Division of Gynecologic Oncology University of Colorado- Denver Anatomy Review
More informationC. VASCONCELOS 1,A.FÉLIX 2 & T. M. CUNHA 3. Journal of Obstetrics and Gynaecology, January 2007; 27(1): Introduction
Journal of Obstetrics and Gynaecology, January 2007; 27(1): 65 70 Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: Comparison of magnetic resonance imaging and
More informationRepeated episodes of spontaneous regression/ progression of cervical adenocarcinoma after adjuvant chemoradiation therapy: a case report
Katano et al. Journal of Medical Case Reports (2015) 9:114 DOI 10.1186/s13256-015-0578-8 CASE REPORT JOURNAL OF MEDICAL CASE REPORTS Open Access Repeated episodes of spontaneous regression/ progression
More informationChapter 8 Adenocarcinoma
Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted
More informationManagement of Neck Metastasis from Unknown Primary
Management of Neck Metastasis from Unknown Primary.. Definition Histologic evidence of malignancy in the cervical lymph node (s) with no apparent primary site of original tumour Diagnosis after a thorough
More informationPET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET
Positron Emission Tomography (PET) When calling Anthem (1-800-533-1120) or using the Point of Care authorization system for a Health Service Review, the following clinical information may be needed to
More informationSTUMPed for a Diagnosis Contemporary Management of Uterine Sarcomas
UCSF Helen Diller Family Comprehensive Cancer Center Disclosures I have no financial disclosures STUMPed for a Diagnosis Contemporary Management of Uterine Sarcomas Lee-may Chen, MD Department of Obstetrics,
More informationColorectal Cancer and FDG PET/CT
Hybrid imaging in colorectal & esophageal cancer Emmanuel Deshayes IAEA WorkShop, November 2017 Colorectal Cancer and FDG PET/CT 1 Clinical background Cancer of the colon and rectum is one of the most
More informationNorth of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer
THIS DOCUMENT North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer Based on WOSCAN CMG with further extensive consultation within NOSCAN UNCONTROLLED WHEN PRINTED DOCUMENT
More informationThe Use of PET Scanning in Urologic Oncology
The Use of PET Scanning in Urologic Oncology Dr Nicholas C. Buchan Uro-oncology Fellow 1 2 Aims To understand the basic concepts underlying PET scanning. Understand the emerging role of PET Scanning for
More informationChapter II.8 Gynecological Tumors
Chapter II.8 Gynecological Tumors Farrokh Dehdashti and Barry A. Siegel Introduction Gynecological cancers as a group comprise approximately 11% of female cancer. 1 In the United States, it is estimated
More informationAbscopal Effect of Radiation on Toruliform Para-aortic Lymph Node Metastases of Advanced Uterine Cervical Carcinoma A Case Report
Abscopal Effect of Radiation on Toruliform Para-aortic Lymph Node Metastases of Advanced Uterine Cervical Carcinoma A Case Report MAMIKO TAKAYA 1, YUZURU NIIBE 1, SHINPEI TSUNODA 2, TOSHIKO JOBO 2, MANAMI
More informationAdjuvant Therapies in Endometrial Cancer. Emma Hudson
Adjuvant Therapies in Endometrial Cancer Emma Hudson Endometrial Cancer Most common gynaecological cancer Incidence increasing in Western world 1-2% cancer deaths 75% patients postmenopausal 97% epithelial
More informationBone and CT Scans Are Complementary for Diagnoses of Bone Metastases in Breast Cancer When PET Scans Findings Are Equivocal: A Case Report
Bone and CT Scans Are Complementary for Diagnoses of Bone Metastases in Breast Cancer When Scans Findings Are Equivocal: A Case Report Yuk-Wah Tsang 1, Jyh-Gang Leu 2, Yen-Kung Chen 3, Kwan-Hwa Chi 1,4
More informationuterine cancer endometrial cancer
2018 ICD-10-CM Diagnosis Code. Adenocarcinoma of endometrium ; Cancer of the. (mucous membrane that lines the endometrial cavity). ICD-10-CM C54.1 is grouped. Home ICD 9 Codes Endometrial Cancer ICD 9
More information